The growing power of some providers to win steep payment increases from insurers suggests policy remedies may be needed

Health Affairs
Robert A BerensonTracy Yee

Abstract

In the constant attention paid to what drives health care costs, only recently has scrutiny been applied to the power that some health care providers, particularly dominant hospital systems, wield to negotiate higher payment rates from insurers. Interviews in twelve US communities indicated that so-called must-have hospital systems and large physician groups--providers that health plans must include in their networks so that they are attractive to employers and consumers--can exert considerable market power to obtain steep payment rates from insurers. Other factors, such as offering an important, unique service or access in a particular geographic area, can contribute to provider leverage as well. Even in markets with dominant health plans, insurers generally have not been aggressive in constraining rate increases, perhaps because the insurers can simply pass along the costs to employers and their workers. Although government intervention--through rate setting or antitrust enforcement--has its place, our findings suggest a range of market and regulatory approaches should be examined in any attempt to address the consequences of growing provider market clout.

References

Jan 1, 1997·Health Affairs·J E McDonough
Jan 14, 2005·Health Affairs·Alison Evans Cuellar, Paul J Gertler
Jun 21, 2006·Journal of Health Politics, Policy and Law·Lawrence P Casalino
Jul 27, 2006·Health Affairs·Robert A BerensonHoangmai H Pham
Nov 7, 2006·Journal of Health Economics·Glenn Melnick, Emmett Keeler
Feb 27, 2010·Health Affairs·Robert A BerensonNicole Kemper
Mar 11, 2011·The New England Journal of Medicine·David Cutler, Leemore Dafny

❮ Previous
Next ❯

Citations

Aug 3, 2012·The New England Journal of Medicine·Ezekiel EmanuelTopher Spiro
Dec 18, 2013·The New England Journal of Medicine·Leemore Dafny
Dec 27, 2013·The New England Journal of Medicine·David BlumenthalDavid Cutler
Sep 25, 2015·Journal of Health Economics·Laurence C BakerDaniel P Kessler
Oct 17, 2012·Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing·Kevin T KavanaghMary-Beth Coty
Jun 14, 2013·The Milbank Quarterly·Teryl K NuckolsSteven M Asch
Sep 10, 2014·The Milbank Quarterly·Jon B ChristiansonLouise H Warrick
Apr 12, 2016·Health Services Research·Sam KrinskyJan Blustein
Mar 10, 2016·Medical Care Research and Review : MCRR·Kathleen Carey
Jun 11, 2016·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Glenn A Melnick, Katya Fonkych
Oct 4, 2017·Journal of Evaluation in Clinical Practice·Jacob WestAshish K Jha
May 4, 2016·Health Affairs·Richard M SchefflerSherry A Glied
Sep 6, 2012·Health Affairs·Neeraj Sood, Aparna Higgins
Aug 10, 2016·Health Affairs·Laurence C BakerDaniel P Kessler
Aug 5, 2015·Health Affairs·Robert A BerensonEmily Lawton
Apr 12, 2018·Health Care Management Review·Tory H HoganNir Menachemi
Oct 1, 2015·Neurology. Clinical Practice·Joel M Kaufman
Jul 7, 2018·Health Services Research·Lawrence P CasalinoStephen M Shortell
Feb 9, 2016·Health Services Research·Daniel J CrespinMichael D Finch
Oct 3, 2018·Health Affairs·Ge Bai, Gerard F Anderson
Jul 3, 2020·International Journal of Health Services : Planning, Administration, Evaluation·Gracie Himmelstein, Kathryn E W Himmelstein
Sep 25, 2017·Health Services Research·Michael F PeskoLawrence P Casalino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.